Clinovi Research
↗Pune, India
Clinovi Research is a global Clinical Research Organization (CRO) headquartered in India, specializing in providing end-to-end clinical trial solutions. The company offers a wide range of services including clinical facility management, bioanalytical studies, clinical data management, and medical writing.
Founded by a team of scientists with over 20 years of experience in Bioavailability and Bioequivalence (BA/BE) studies, Clinovi focuses on trust, transparency, and ethical practices. They cater to both the biopharmaceutical and generic drug industries, helping clients navigate the regulatory landscape and accelerate product development through innovative technologies and therapeutic expertise.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:$0M-$1M
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:Unfunded
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Generics, Biologics
Active Trials:5
Trial Phases:Phase 1: 2 | Phase 2: 1 | Phase 3: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Balaji Institute of Pharmaceutical Sciences (MoU for research/training), Samahitha Research Solutions (Clinical trial site collaboration)
COMPETITION
Position:Emerging
Competitors:Clario, Lightship, CRYOPDP, SFJ Pharmaceuticals, Clinovo
LEADERSHIP
Key Executives:
Narsimha Rao P - Managing Director
Rajesh Suvvaru Kumar - Director
Radhika Inapakolla - Director
Scientific Founders:Narsimha Rao P
Board Members:Rajesh Suvvaru Kumar, Radhika Inapakolla, Kondareddy Kurukuntla
LINKS
Website:clinovi.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Clinovi Research. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.